An interventional study of SMART Mobile App - Attention Bias Modification and SMART Mobile App - Attention Control Training in Post Traumatic Stress Disorder, sponsored by University of California, San Francisco. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-10-30.
Sponsored by University of California, San Francisco · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 17 studies in Stress Disorders, Post-Traumatic by University of California, San Francisco — 2 open to participants now, 2 under way, none of them phase 3. Stress Disorders, Post-Traumatic · University of California, San Francisco.
Among the 17 studies in Stress Disorders, Post-Traumatic by University of California, San Francisco, this one is the 2nd largest by enrollment of the 14 interventional ones that give a count, is one of 2 that started in 2023, is one of 9 with no phase, and was the 15th registered.
2,689 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 605 are open to participants now.
Browse Stress Disorders, Post-Traumatic studies →2 of the 17 studies in Stress Disorders, Post-Traumatic by University of California, San Francisco are open now, in 1 country. Recruiting first, the newest first:
University of California, San Francisco · Sites in United States
Ages 18–65 · Healthy volunteers
University of California, San Francisco · Sites in United States
Ages 18+ · Healthy volunteers
By country, each count listing its studies:
Of the 416 Stress Disorders, Post-Traumatic studies recruiting now, 188 (45%) set no upper age limit and 202 (49%) stop at 75 or younger; 62 take children under 18; 88 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
17 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 2 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 872 is above the median of 69 across 2,203 interventional studies indexed under Stress Disorders, Post-Traumatic.
Median enrollment 74 across the 14 interventional studies, 100,004 across the 2 observational. Of the 14 that completed or were terminated, 8 (57%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of California, San Francisco is the lead sponsor of 2,172 studies on the registry; 370 are open to participants now.
Of its 269 completed or terminated interventional studies of FDA-regulated products, 203 (75%) have results posted.
None of the studies under way reaches primary completion within a year.
Among the 17 studies in Stress Disorders, Post-Traumatic by University of California, San Francisco, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The investigators will complete an entirely remote randomized controlled trial (RCT) comparing 14 sessions of attention bias modification (ABM), attention control training (ACT), placebo neutral attention training, and a final control condition with daily questions in 1,897 individuals with clinically significant Post-traumatic Stress Symptoms (PTSS) (defined as PCL-5 score ≥ 33). To assess effects of the training and control conditions, the investigators will administer tests of threat-related attention bias and variability, and self-report assessments of PTSS, depression, anxiety, and perceived stress at baseline, after one and two weeks of training, and at eight-week follow up. The investigators plan to screen and confirm interest from over 3,000 eligible participants over a period of 24 months to enroll and randomize 1,897 participants with the end goal of 1,232 completers (176 per condition).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Attention bias modification training involves a probe detection task as follows: (1) a fixation cross appears on the screen for 500ms; (2) the fixation cross is replaced by two target stimuli (one threat word and one neutral word) that are displayed at the top and the bottom of the screen for 500ms; (2) the stimuli disappear and a visual probe appears (the letter E or F), in the location of one of the two stimuli until the participant responds to indicate whether the letter was an E or an F using response buttons at the bottom of the phone screen. In the active ABM condition, the probe replaces the neutral stimulus 100% of the time.
Device: SMART Mobile App - Attention Bias Modification
Attention bias modification training involves a probe detection task as follows: (1) a fixation cross appears on the screen for 500ms; (2) the fixation cross is replaced by two target stimuli (one threatening face and one neutral face) that are displayed at the top and the bottom of the screen for 500ms; (2) the stimuli disappear and a visual probe appears (the letter E or F), in the location of one of the two stimuli until the participant responds to indicate whether the letter was an E or an F using response buttons at the bottom of the phone screen. In the active ABM condition, the probe replaces the neutral stimulus 100% of the time.
Device: SMART Mobile App - Attention Bias Modification
Attention control training involves a probe detection task as follows: (1) a fixation cross appears on the screen for 500ms; (2) the fixation cross is replaced by two target stimuli (i.e. one threat word and one neutral word) that are displayed at the top and the bottom of the screen for 500ms; (2) the stimuli disappear and a visual probe appears (the letter E or F), in the location of one of the two stimuli until the participant responds to indicate whether the letter was an E or an F using response buttons at the bottom of the phone screen. In the active ACT condition, the probe replaces the neutral stimulus 50% of the time, and replaces the threat stimulus the other 50%.
Device: SMART Mobile App - Attention Control Training
Attention control training involves a probe detection task as follows: (1) a fixation cross appears on the screen for 500ms; (2) the fixation cross is replaced by two target stimuli (one threatening face and one neutral face) that are displayed at the top and the bottom of the screen for 500ms; (2) the stimuli disappear and a visual probe appears (the letter E or F), in the location of one of the two stimuli until the participant responds to indicate whether the letter was an E or an F using response buttons at the bottom of the phone screen. In the active ACT condition, the probe replaces the neutral stimulus 50% of the time, and replaces the threat stimulus the other 50%.
Device: SMART Mobile App - Attention Control Training
Placebo attention training involves a probe detection task as follows: (1) a fixation cross appears on the screen for 500ms; (2) the fixation cross is replaced by two target stimuli (two neutral words) that are displayed at the top and the bottom of the screen for 500ms; (2) the stimuli disappear and a visual probe appears (the letter E or F), in the location of one of the two stimuli until the participant responds to indicate whether the letter was an E or an F using response buttons at the bottom of the phone screen.
Device: SMART Mobile App - Placebo Training
Placebo attention training involves a probe detection task as follows: (1) a fixation cross appears on the screen for 500ms; (2) the fixation cross is replaced by two target stimuli (two neutral faces) that are displayed at the top and the bottom of the screen for 500ms; (2) the stimuli disappear and a visual probe appears (the letter E or F), in the location of one of the two stimuli until the participant responds to indicate whether the letter was an E or an F using response buttons at the bottom of the phone screen.
Device: SMART Mobile App - Placebo Training
The Control - Questions condition will only deliver a set of daily questions for participants to answer. Questions will ask about a variety of psychological factors such as mood, stress experiences, daily exercise and more.
Device: SMART Mobile App - Control
ABM involves placing the probe behind the neutral stimulus on 100% of the trials.
ACT involves placing the probe behind the neutral stimulus on 50% of trials, and behind the threat stimulus on 50% of trials.
Placebo training only includes neutral stimuli.
Participants will only answer questions.
Change in PTSD Checklist-5 (PCL) Score (Before/After Training)
Reported are the changes in the PTSD Checklist for the DSM-5 (PCL-5) scores between baseline (Day 1) and post-training (Day 28) in each group. The PCL-5 assesses the presence and severity of 20 different symptoms in posttraumatic stress disorder (PTSD). Each of the 20 items is scored on a severity range of 0 ("Not at All") to 4 ("Extremely"), for a final score range of 0 - 80. A score of 33 and above is indicative of clinically significant PTSD symptoms. Higher scores indicate worse PTSD symptom severity. A 10 point change (up or down) is considered a clinically significant change in PTSD symptoms.
Time frame: Baseline, 4 weeks
Change in PTSD Checklist-5 (PCL) Score (Follow-up)
Reported are the changes in the PTSD Checklist for the DSM-5 (PCL-5) scores between post-training (Day 28) and follow-up (Day 56) in each group. The PCL-5 assesses the presence and severity of 20 different symptoms in posttraumatic stress disorder (PTSD). Each of the 20 items is scored on a severity range of 0 ("Not at All") to 4 ("Extremely"), for a final score range of 0 - 80. A score of 33 and above is indicative of clinically significant PTSD symptoms. Higher scores indicate worse PTSD symptom severity. A 10 point change (up or down) is considered a clinically significant change in PTSD symptoms.
Time frame: 4 weeks, 8 Weeks
| Milestone | Attention Bias Modification - Word Stimuli | Attention Bias Modification - Face Stimuli | Attention Control Training - Word Stimuli | Attention Control Training - Face Stimuli | Placebo Attention Training - Word Stimuli | Placebo Attention Training - Face Stimuli | Control - Questions |
|---|---|---|---|---|---|---|---|
| Started | 123 | 126 | 124 | 124 | 127 | 125 | 123 |
| Completed | 71 | 71 | 72 | 85 | 78 | 82 | 87 |
| Not completed | 52 | 55 | 52 | 39 | 49 | 43 | 36 |
| Milestone | Attention Bias Modification - Word Stimuli | Attention Bias Modification - Face Stimuli | Attention Control Training - Word Stimuli | Attention Control Training - Face Stimuli | Placebo Attention Training - Word Stimuli | Placebo Attention Training - Face Stimuli | Control - Questions |
|---|---|---|---|---|---|---|---|
| Started | 71 | 71 | 72 | 85 | 78 | 82 | 87 |
| Completed | 67 | 66 | 64 | 79 | 73 | 65 | 72 |
| Not completed | 4 | 5 | 8 | 6 | 5 | 17 | 15 |
Reported are the changes in the PTSD Checklist for the DSM-5 (PCL-5) scores between baseline (Day 1) and post-training (Day 28) in each group. The PCL-5 assesses the presence and severity of 20 different symptoms in posttraumatic stress disorder (PTSD). Each of the 20 items is scored on a severity range of 0 ("Not at All") to 4 ("Extremely"), for a final score range of 0 - 80. A score of 33 and above is indicative of clinically significant PTSD symptoms. Higher scores indicate worse PTSD symptom severity. A 10 point change (up or down) is considered a clinically significant change in PTSD symptoms.
| Scores on a scale | Attention Bias Modification - Word Stimuli | Attention Bias Modification - Face Stimuli | Attention Control Training - Word Stimuli | Attention Control Training - Face Stimuli | Placebo Attention Training - Word Stimuli | Placebo Attention Training - Face Stimuli | Control - Questions |
|---|---|---|---|---|---|---|---|
| Change in PTSD Checklist-5 (PCL) Score (Before/After Training) | -4.54 ± 15.06 | -5.37 ± 14.42 | -4.65 ± 15.1 | -6.73 ± 11.71 | -3.81 ± 12.97 | -4.79 ± 12.79 | -2.66 ± 12.99 |
Reported are the changes in the PTSD Checklist for the DSM-5 (PCL-5) scores between post-training (Day 28) and follow-up (Day 56) in each group. The PCL-5 assesses the presence and severity of 20 different symptoms in posttraumatic stress disorder (PTSD). Each of the 20 items is scored on a severity range of 0 ("Not at All") to 4 ("Extremely"), for a final score range of 0 - 80. A score of 33 and above is indicative of clinically significant PTSD symptoms. Higher scores indicate worse PTSD symptom severity. A 10 point change (up or down) is considered a clinically significant change in PTSD symptoms.
| Scores on a scale | Attention Bias Modification - Word Stimuli | Attention Bias Modification - Face Stimuli | Attention Control Training - Word Stimuli | Attention Control Training - Face Stimuli | Placebo Attention Training - Word Stimuli | Placebo Attention Training - Face Stimuli | Control - Questions |
|---|---|---|---|---|---|---|---|
| Change in PTSD Checklist-5 (PCL) Score (Follow-up) | -4.42 ± 15.51 | -4.74 ± 19.32 | -6.14 ± 15.8 | -5.04 ± 12.61 | -7.27 ± 16.5 | -4.72 ± 12.77 | -8.65 ± 17.22 |
Collected over From baseline assessment until the end of follow-up, approximately 8 weeks.. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Attention Bias Modification - Word Stimuli | 0/123 (0%) | 0/123 (0%) | 0/123 (0%) |
| Attention Bias Modification - Face Stimuli | 0/126 (0%) | 0/126 (0%) | 0/126 (0%) |
| Attention Control Training - Word Stimuli | 0/124 (0%) | 0/124 (0%) | 0/124 (0%) |
| Attention Control Training - Face Stimuli | 0/124 (0%) | 0/124 (0%) | 0/124 (0%) |
| Placebo Attention Training - Word Stimuli | 0/127 (0%) | 0/127 (0%) | 0/127 (0%) |
| Placebo Attention Training - Face Stimuli | 0/125 (0%) | 0/125 (0%) | 0/125 (0%) |
| Control - Questions | 0/123 (0%) | 0/123 (0%) | 0/123 (0%) |
Baseline measures (i.e., age, gender, race/ethnicity) were collected for all participants who completed screening surveys.
| Age, Continuous(Years) | Attention Bias Modification - Word Stimuli | Attention Bias Modification - Face Stimuli | Attention Control Training - Word Stimuli | Attention Control Training - Face Stimuli | Placebo Attention Training - Word Stimuli | Placebo Attention Training - Face Stimuli | Control - Questions | Total |
|---|---|---|---|---|---|---|---|---|
| Mean | 32 ± 10 | 33 ± 11 | 31 ± 9 | 31 ± 9 | 30 ± 8 | 32 ± 9 | 32 ± 8 | 32 ± 9 |
| Sex/Gender, Customized(Participants) | Attention Bias Modification - Word Stimuli | Attention Bias Modification - Face Stimuli | Attention Control Training - Word Stimuli | Attention Control Training - Face Stimuli | Placebo Attention Training - Word Stimuli | Placebo Attention Training - Face Stimuli | Control - Questions | Total |
|---|---|---|---|---|---|---|---|---|
| Man | 35 | 33 | 42 | 47 | 43 | 46 | 40 | 286 |
| Woman | 81 | 87 | 77 | 73 | 75 | 73 | 77 | 543 |
| Other | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 9 |
| Missing | 6 | 5 | 4 | 3 | 8 | 4 | 4 | 34 |
| Race/Ethnicity, Customized(Participants) | Attention Bias Modification - Word Stimuli | Attention Bias Modification - Face Stimuli | Attention Control Training - Word Stimuli | Attention Control Training - Face Stimuli | Placebo Attention Training - Word Stimuli | Placebo Attention Training - Face Stimuli | Control - Questions | Total |
|---|---|---|---|---|---|---|---|---|
| Race/Ethnicity — American Indian / Alaskan | 0 | 1 | 0 | 2 | 0 | 0 | 2 | 5 |
| Race/Ethnicity — Asian | 4 | 8 | 2 | 7 | 8 | 1 | 7 | 37 |
| Race/Ethnicity — Black / African American | 26 | 31 | 31 | 29 | 31 | 38 | 29 | 215 |
| Race/Ethnicity — Hispanic / Latinx | 2 | 2 | 3 | 3 | 3 | 2 | 6 | 21 |
| Race/Ethnicity — Middle Eastern / North African | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 5 |
| Race/Ethnicity — Native Hawaiian / Pacific Islander | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 2 |
| Race/Ethnicity — White / Caucasian | 54 | 49 | 50 | 57 | 56 | 58 | 47 | 371 |
| Race/Ethnicity — Missing | 36 | 34 | 37 | 24 | 29 | 26 | 30 | 216 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Apr 2023 to primary completion in Jun 2025, 26 months.
Results were first posted in Oct 2026, 1 year 4 months after primary completion. A results delay was requested in Jun 2026.
Of 1,066 non-industry interventional studies with no phase under Stress Disorders, Post-Traumatic, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's 26 months is below that.
Counting every sponsor, half of 1,094 studies reached it within 35 months; a quarter within 17 and three quarters within 53.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Stress Disorders, Post-Traumatic →
University of California, San Francisco →